07:00 , Oct 10, 2013 |  BC Innovations  |  Distillery Therapeutics

Indication: Pulmonary disease

Indication Target/marker/pathway Summary Licensing status Publication and contact information Pulmonary disease Cystic fibrosis (CF) Diacylglycerol kinase-i (DGKI); epithelial sodium channel (ENaC) In vitro and cell culture studies suggest DGKI inhibition could help treat CF. An...